← Back to headlines

Commentary Criticizes Over-Evaluation of New Skin Cancer Therapy
A commentary criticizes the exaggerated assessment of a new combination therapy for skin cancer involving an mRNA vaccine, arguing that while the therapy is good for delaying tumor recurrence, calling it a 'big day for humanity' is counterproductive and harmful.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
